Pharmaceutical
Biopharmaceutical
Biotechnology

ImmunoGen

10,242

$3.28
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.00 (+0.15%) As of 2:18 PM EST today
+$0.00 (+0.15%) Today

Why Robinhood?

You can buy or sell ImmunoGen and other stocks, options, ETFs, and crypto commission-free!

About IMGN

ImmunoGen, Inc. Common Stock, also called ImmunoGen, is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Read More Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.

CEO
Mark J. Enyedy
Employees
296
Headquarters
Waltham, Massachusetts
Founded
1981
Market Cap
489.50M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
2.16M
High Today
$3.32
Low Today
$3.19
Open Price
$3.22
Volume
534.88K
52 Week High
$6.13
52 Week Low
$1.76

Collections

Pharmaceutical
Biopharmaceutical
Biotechnology
Therapy
Cancer Prevention
Technology
Health
US

IMGN News

ReutersNov 10

Edited Transcript of IMGN earnings conference call or presentation 1-Nov-19 12:00pm GMT

Q3 2019 ImmunoGen Inc Earnings Call WALTHAM Nov 10, 2019 (Thomson StreetEvents) -- Edited Transcript of ImmunoGen Inc earnings conference call or presentation
20

IMGN Earnings

-$0.33
-$0.27
-$0.21
-$0.15
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
-$0.18 per share
Actual
-$0.15 per share
Replay Earnings Call

You May Also Like

EPM
ASPU
WHFBZ
VRTU
FXG
ZM
MBII
WOR
MTR
DX-B
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy IMGN

Market Price$3.28
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell ImmunoGen stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up